Labcorp Holdings Files 8-K Report
Ticker: LH · Form: 8-K · Filed: Jul 1, 2024 · CIK: 920148
| Field | Detail |
|---|---|
| Company | Labcorp Holdings Inc. (LH) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.10 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, disclosure
Related Tickers: LH
TL;DR
Labcorp filed a routine 8-K, no major news.
AI Summary
On July 1, 2024, LABCORP HOLDINGS INC. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but the filing indicates standard reporting procedures.
Why It Matters
This filing indicates LABCORP HOLDINGS INC. is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report for disclosure and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- LABCORP HOLDINGS INC. (company) — Registrant
- 0000920148-24-000090 (filing_id) — Accession Number
- July 1, 2024 (date) — Filing Date
- 358 South Main Street, Burlington, North Carolina 27215 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for LABCORP HOLDINGS INC.?
The filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is LABCORP HOLDINGS INC.
On what date was this 8-K filing submitted?
The filing was submitted on July 1, 2024.
Where are LABCORP HOLDINGS INC.'s principal executive offices located?
The principal executive offices are located at 358 South Main Street, Burlington, North Carolina 27215.
What is the Commission File Number for LABCORP HOLDINGS INC.?
The Commission File Number is 1-11353.
Filing Stats: 435 words · 2 min read · ~1 pages · Grade level 10.7 · Accepted 2024-07-01 09:38:04
Key Financial Figures
- $0.10 — nge on which registered Common Stock , $0.10 par value LH New York Stock Exchange
Filing Documents
- lh-20240701.htm (8-K) — 24KB
- formpr2q24ex991earningsann.htm (EX-99.1) — 6KB
- lc2020logov2.gif (GRAPHIC) — 5KB
- 0000920148-24-000090.txt ( ) — 161KB
- lh-20240701.xsd (EX-101.SCH) — 2KB
- lh-20240701_lab.xml (EX-101.LAB) — 22KB
- lh-20240701_pre.xml (EX-101.PRE) — 12KB
- lh-20240701_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Exhibit Name Exhibit 99.1 Press release dated July 1 , 2024 issued by Labcorp
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABCORP HOLDINGS INC. Registrant By: /s/ SANDRA VAN DER VAART Sandra van der Vaart Executive Vice President, Chief Legal Officer and Corporate Secretary July 1, 2024